Author, year | Patients (n) | Daily AIVR burden (%) | LVEF | Treatment | Follow-up (duration and outcome) |
---|---|---|---|---|---|
Bergdahl [15] | 2 | Unknown | Normal | AAD | 6 months, 20 months; complete recovery |
Bisset [16] | 3 | Unknown | Normal | AAD 1/3 | 6 months–2 years; complete recovery |
Scagliotti [17] | 8 | Unknown | Unknown | AAD• | unknown |
Van Hare [18] | 12 | Unknown | Unknown | AAD 4/12 | 2 months–11 years; complete recovery in patients without AAD and in patients on AAD after withdraw; 2 patients died from other causes |
MacLellan [6] | 2 | Unknown | Unknown | No | 31 months–16 years; complete recovery |
Kurotobi [19] | 1 | Unknown | Unknown | Unknown | 2 years; complete recovery |
Anatoliotaki [20] | 2 | Unknown | Unknown | AAD 1/2 | 6–18 months; complete recovery |
Rehsia [14] | 1 | “Intermittent” | Normal | AAD | 6 months; complete recovery |
Roggen [21] | 3 | Unknown | Unknown | No | unknown* |
Freire [22] | 4 | Unknown | Unknown | AAD 2/4 | 2 months–1 year; complete recovery |
Wang [7] | 6 | Unknown | Normal | Unknown | Unknown* |